The effect of appropriate antimicrobial therapy on 14-day mortality in patients severely ill with Acinetobacter baumannii bacteremic pneumonia was assessed, taking risk factors, patient demographics, and clinical characteristics into account.
Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality.
Study authors assessed the relationship between children living in contact with sputum smear-positive tuberculosis patients on DOTS and children getting infected with tuberculosis or tubercular infection.
Fluticasone/salmeterol and budesonide/formoterol are common treatments for COPD; researchers investigated whether these treatments may be correlated with active tuberculosis risk.
The randomized, open-label, controlled trial (Study 31/A5349) had more than 2500 participants ages 12 years and older and included 214 people with HIV.
Researchers linked the use of 2 hypertension drug classes to lower mortality for those hospitalized with flu and pneumonia.
Intravenous antibiotics do not achieve greater sustained eradication of Pseudomonas aeruginosa in patients with cystic fibrosis compared with oral therapy.
New study published in the European Respiratory Journal suggest that in most settings, the odds of drug resistance are the same for children and adults with TB, consistent with past research.
There was very low influenza activity during June to August 2020 in the Southern Hemisphere.
The observational study aimed to determine the association between fluoroquinolone use and the risk of aortic aneurysm or aortic dissection while taking into account potential confounding.
Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality.
Fetal exposure to the H1N1 vaccine is not associated with an increased risk for autism spectrum disorder or autistic disorder in children.
Researchers compared HAdV-3 with HAdV-7 replication kinetics and host response in ex vivo human lung tissue cultures.
The rate of acute cardiovascular events was found to be high in adults hospitalized with influenza.
For patients with heart failure, influenza and pneumococcal vaccinations are associated with lower in-hospital mortality.
The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.
Younger patients with asthma who were hospitalized with COVID-19 did not have worse outcomes than patients hospitalized with COVID-19 without asthma.
The aim of this study was to evaluate the invasive disease potential of non-PCV13 serotypes after implementation of this vaccine.
For upper respiratory tract infections (URTIs), honey seems superior to usual care.
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.